Multicenter observational study of BRAFV600E mutation in patients with resected colorectal liver metastasis

Multicenter observational study of BRAFV600E mutation in patients with resected colorectal liver metastasis - BRAVE study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034557

Enrollment

500

Registered

2018-10-19

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

resected colorectal liver metastasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: resected colorectal liver metastasis

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
rate of BRAFV600E mutation	—

Secondary

Measure	Time frame
prognosis regarding below staratification RAS/BRAF wild type, RAS mutation,BRAF mutation BRAFV600E mutation, non BRAFV600E mutation *dMMR, pMMR	—

Countries

Japan

Contacts

Public ContactShin Kobayashi

National Cancer Center Hospital East Hepatobiliary and pancreatic surgery

shkobaya@east.ncc.go.jp04-7133-1111

Outcome results